Carbon monoxide inhibits the nuclear-cytoplasmic translocation of HMGB1 in an in vitro oxidative stress injury model of mouse renal tubular epithelial cells

Abstract

Carbon monoxide (CO), as a vital small molecule in signaling pathways, is found to be involved in ischemia-reperfusion injury (IRI) in renal transplantation. CO-releasing molecule-2 (CORM-2), a CO-releasing molecule, is a type of metal carbonyl complexes which can quickly release CO in vivo. In this study, an in vitro oxidative stress injury model was established to examine the effect of CORM-2 pretreatment on the nuclear-cytoplasmic translocation of high mobility group box 1 protein (HMGB1) in mouse primary renal proximal tubular epithelial cells (RPTECs). Immunofluorescence staining showed that HMGB1 in the medium- and CORM-2-treated groups was predominantly localized in the nucleus of the cells, whereas higher amounts of HMGB1 translocated to the cytoplasm in the H₂O₂- and inactive CORM-2 (iCORM-2)-treated groups. Western blotting of HMGB1 showed that the total amounts of cytoplasmic HMGB1 in the H₂O₂-treated (0.59±0.27) and iCORM-2-treated (0.57±0.22) groups were markedly higher than those in the medium-treated (0.19±0.05) and CORM-2-treated (0.21±0.10) groups (P<0.05). Co-immunoprecipitation showed that the levels of acetylated HMGB1 in the H₂O₂-treated (642.98±57.25) and iCORM-2-treated (342.11±131.25) groups were markedly increased as compared with the medium-treated (78.72±74.17) and CORM-2-treated (71.42±53.35) groups (P<0.05), and no significant difference was observed between the medium-treated and CORM-2-treated groups (P>0.05). In conclusion, our study demonstrated that in the in vitro oxidative stress injury model of primary RPTECs, CORM-2 can significantly inhibit the nuclear-cytoplasmic translocation of HMGB1, which is probably associated with the prevention of HMGB1 acetylation.

Keywords

renal tubules / epithelial cell / oxidative stress / HMGB1 protein / carbon monoxide / acetylation

References

[1] SadisC, TeskeG, StokmanG, et al. . Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One, 2007, 2(5): 469

[2] LiJ, GongQ, ZhongS, et al. . Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant, 2011, 26(2): 469-478 PMID: 20679140

[3] WuH, MaJ, WangP, et al. . HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol, 2010, 21(11): 1878-1890 PMID: 20847143 PMCID: 3014003

[4] AsavarutP, ZhaoH, GuJ, MaD. The role of HMGB1 in inflammation-mediated organ injury. Acta Anaesthesiol Taiwan, 2013, 51(1): 28-33 PMID: 23711603

[5] ZhaoH, WattsHR, ChongM, et al. . Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats. Am J Transplant, 2013, 13(8): 2006-2018 PMID: 23710625 PMCID: 3884761

[6] TsoyiK, LeeTY, LeeYS, et al. . Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS-and cecal ligation and puncture-induced sepsis model in vivo. Mol Pharmacol, 2009, 76(1): 173-182 PMID: 19366789

[7] RuanY, WangL, ZhaoY, et al. . Carbon monoxide potently prevents ischemia-induced high-mobility group box 1 translocation and release and protects against lethal renal ischemia-reperfusion injury. Kidney Int, 2014, 86(3): 525-537 PMID: 24694987

[8] CaumartinY, StephenJ, DengJP, et al. . Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int, 2011, 79(10): 1080-1089 PMID: 21270767

[9] KluneJR, DhuparR, CardinalJ, et al. . HMGB1: endogenous danger signaling. Mol Med, 2008, 14(7-8): 476-484 PMID: 18431461 PMCID: 2323334

[10] RabadiMM, GhalyT, GoligorksyMS, et al. . HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol, 2012, 303(6): F873-F885 PMID: 22759395 PMCID: 3468521

[11] ZhaoH, PerezJS, LuK, et al. . Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol, 2014, 306(8): F801-F811 PMID: 24523386 PMCID: 3989634

[12] ChangBP, WangDS, XingJW, et al. . miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1. J Huazhong Univ Sci Technol [Med Sci], 2014, 34(2): 201-201

[13] TsungA, SahaiR, TanakaH, et al. . The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med, 2005, 201(7): 1135-1143 PMID: 15795240 PMCID: 2213120

[14] AndrassyM, VolzHC, IgweJC, et al. . High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation, 2008, 117(25): 3216-3226 PMID: 18574060

[15] EvankovichJ, ChoSW, ZhangR, et al. . High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem, 2010, 285(51): 39888-39897 PMID: 20937823 PMCID: 3000970

[16] BonaldiT, TalamoF, ScaffidiP, et al. . Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J, 2003, 22(20): 5551-5560 PMID: 14532127 PMCID: 213771

[17] OzakiKS, KimuraS, MuraseN. Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation. Transplant Rev, 2012, 26(2): 125-139

[18] MotterliniR, ClarkJE, ForestiR, et al. . Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res, 2002, 90(2): 17-E24

[19] WeiY, ChenP, de BruynM, et al. . Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol, 2010, 10: 42 PMID: 20444253 PMCID: 2873601

[20] KatadaK, BihariA, MizuguchiS, et al. . Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation, 2010, 33(2): 92-100 PMID: 19842024

[21] SaharaH, ShimizuA, SetoyamaK, et al. . Carbon monoxide reduces pulmonary ischemia-reperfusion injury in miniature swine. J Thorac Cardiovasc Surg, 2010, 139(6): 1594-1601 PMID: 19909986